Aia Group LTD Catalent, Inc. Transaction History

Aia Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$45.44 - $74.26 $40,532 - $66,239	892 Added 11.65%	8,551 $561,000
Q4 2022 Jan 31, 2023	BUY	$41.39 - $81.0 $49,295 - $96,471	1,191 Added 18.41%	7,659 $344,000
Q3 2022 Nov 04, 2022	BUY	$72.36 - $113.1 $147,107 - $229,932	2,033 Added 45.84%	6,468 $468,000
Q2 2022 Aug 11, 2022	SELL	$87.2 - $114.05 $23,718 - $31,021	-272 Reduced 5.78%	4,435 $476,000
Q1 2022 May 06, 2022	BUY	$94.19 - $124.49 $221,723 - $293,049	2,354 Added 100.04%	4,707 $522,000
Q4 2021 Feb 11, 2022	BUY	$119.57 - $139.07 $281,348 - $327,231	2,353 New	2,353 $301,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Aia Group LTD, based on Form 13F filings with the SEC.

Stay updated on Aia Group LTD with notifications on news.